20/20 Biolabs Inc. (AIDX) vs Imunon, Inc. (IMNN)

A side-by-side comparison of 20/20 Biolabs Inc. and Imunon, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.34HealthcareDelayed quote: Oct 6, 2026, 10:58 AM EDT
Imunon, Inc. logo
IMNN
Imunon, Inc.
$5M
$1.20HealthcareDelayed quote: Oct 6, 2026, 10:53 AM EDT

Total return — AIDX vs IMNN

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)IMNN -61.8% (-61.8%/yr)IMNN compounded faster over this window
Log scale — wide-divergence pair
110100Start $100$1$38
AIDX IMNN

AIDX vs IMNN: by the numbers

  • •IMNN is the larger company ($5M vs $4M market cap).
  • •Both run net losses; IMNN's is the smaller (0.00% vs -285.00% net margin).

Metrics side by side

Valuation

MetricAIDXIMNN
P/S ratio2.07N/A
P/B ratio2.601.20

Profitability

MetricAIDXIMNN
Gross margin31.52%0.00%
Operating margin-162.87%0.00%
Net margin-285.00%0.00%
ROE-184.04%-351.30%
ROIC-116.89%-126.69%

Growth (annualized)

MetricAIDXIMNN
Revenue CAGR (5Y)-2.58%N/A
Total return CAGR (5Y)N/A-63.83%

Go deeper

Full AIDX analysisFull IMNN analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROEImunon ROE20/20 Biolabs operating marginImunon operating margin20/20 Biolabs revenue growthImunon revenue growth20/20 Biolabs free cash flowImunon free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.